CHIUN HSURimassa L.Sun H.-C.Vogel A.Kaseb A.O.2022-08-192022-08-1920211758-8340https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111475007&doi=10.1177%2f17588359211031141&partnerID=40&md5=715daa24c061bb51ee109c493b32fd33https://scholars.lib.ntu.edu.tw/handle/123456789/617102Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumabreview10.1177/175883592110311412-s2.0-85111475007